Half-yearly report
THE CORE BUSINESS PLC
("TCB" or the "Company")
Preliminary Results for the half year to 30 November 2007
21 January 2008
HIGHLIGHTS
· Completed the acquisition of Amirose International in July 2007
· Revenue for the half year increased by over 12 fold to £972,000 versus £78,000 for the half year period last year.
· Distribution revenue delivered group sales of £930,000 versus £Nil for the half year period last year. Of this, 51%
was generated by The Core Business and 49% by Amirose International.
· Signed an agreement with Ulric de Varens SA, a Bourse-listed leading French mass fragrance manufacturer, to
establish and manage a joint venture in the UK.
· Strong flow of new distribution opportunities and own brand projects with several launches agreed by major retailers
in early 2008.
CHAIRMAN'S STATEMENT
The Amirose acquisition last July has added significantly to the Group's spread of activity, giving it a strategically
important distribution capability and Far Eastern manufacturing contacts. It has also boosted the range of products that
we sell to major retail operations that include Tesco, Superdrug, Asda and own label supply for Marks and Spencer.
The distribution side of the business is moving apace and substantial sales are already contracted for the rest of 2008
including the launch of a further colour cosmetics brand into Superdrug and a skincare product into Tesco. We are
particularly pleased with the potential of the Elite Models Fashion ranges of cosmetics and manicure and hair
accessories products. The cosmetics range is listed in 200 Superdrug stores and manicure and hair accessories in over
350 stores. A further roll out of selected Elite Models Fashion products in early 2008 has been agreed with a major
retailer.
Sales and distribution agreements with other international brands are under review as are the development and launch of
our own brands.
The signing of the agreement with Ulric de Varens provides The Core Business with a 20% shareholding in a UK subsidiary
and a long term monthly management fee. The Core Business has delivered quick results with a selection of Ulric De
Varens fragrances launching in 300 Superdrug stores in January 2008.
Consultancy, although no longer a key driver of revenue for the company, will continue to receive focus as a provider of
business opportunities.
The Core Business maintains a close dialogue with all leading retailers and is continually assessing brand opportunities
within the personal care market. Although the time taken to bring new brands to market can be lengthy we are very
confident that our efforts will show good returns over the coming years.
FINANCIAL OVERVIEW
Turnover for the six months to 30 November 2007 was £972,000 (six months to 30 November 2006: £78,000) and the loss for
the half year was £143,000 (six months to 30 November 2006: £179,000 loss) equivalent to 0.10 pence loss per share (six
months to 30 November 2006: 0.43 pence loss per share). Of this total turnover figure The Core Business generated
£518,000 and Amirose £454,000.
The Group's net assets at 30 November were £1,430,000, £1,345,000 higher than at 31 May 2007. The increase is due to
the issue of shares for cash to acquire Amirose International Limited in July 2007. Total liabilities were £1,221,000,
an increase of £903,000 since 31 May 2007. The increase is due to the issue of loan notes to acquire Amirose.
In line with our previous statements we have focused our business on distributing brands and have generated over
£930,000 in distribution revenue in the six months to 30 November 2007 compared with £Nil in the comparative period last
year. Of this 51% was generated by The Core Business and 49% by Amirose International which was acquired in July 2007.
Consultancy revenue for the period was down from £78,000 to £38,000 reflecting our focus on distributing brands and
being selective in our choice of consultancy projects.
The results for the six months to 30 November 2007 include exceptional costs of £149,000 in relation to facility costs.
These costs were incurred in putting in place the financing for the acquisition of Amirose International.
OUTLOOK
We have started to see a major uplift in our business, not just through the acquisition of Amirose but also through the
brands distributed by The Core Business and are excited at the massive potential leading into next six months. In the
half year to 30 November 2007 we have made important progress in the delivery of our strategy; our distribution business
has been launched and is on a strong footing and we have completed our first acquisition. With the combined efforts of
Amirose and The Core Business we have an aggressive plan in place to launch further brands throughout 2008 and a great
deal of work has already gone into negotiating supplier and retailer contracts. We are confident that our strategy to
focus on distributing and developing brands leaves us well placed to create value for our shareholders in the years to
come.
Mark Watson-Mitchell
Chairman
For further information, please contact:
The Core Business plc
Stirling Murray, Chief Executive 020 7483 4300
Ellis Stockbrokers Limited
Neil Badger 01293 517 744
Blomfield Corporate Finance Limited
Nick Harriss 020 7512 0191
BALANCE SHEET
HALF YEAR ENDED 30 NOVEMBER 2007
As at As at As at
Notes 30/11/07 30/11/06 31/5/07
£ £ £
Assets
Non-current assets
Property, plant and equipment 115,365 1,325 1,507
Financial assets 21,706 20,578 21,706
Goodwill 1,648,971 - -
___________________________________
1,786,042 21,903 23,213
Current Assets
Inventories 399,191 - 5,510
Trade receivables 285,501 17,537 52,395
Other current assets 710 32,688 156,886
Cash and cash equivalents 179,802 273,210 79,576
___________________________________
865,204 323,435 294,367
___________________________________
Total assets 2,651,246 345,338 317,580
===================================
Equity and liabilities
Equity attributable to the Company's
equity holders
Share capital 4 1,016,776 211,982 211,982
Share premium 1,095,794 411,913 411,913
Retained earnings (682,565) (310,904) (539,267)
___________________________________
1,430,005 312,991 84,628
Current liabilities
Trade and other payables 459,497 32,347 232,952
Loan notes 460,313 - -
___________________________________
919,810 32,347 232,952
Non Current liabilities
Loan notes 301,431 - -
___________________________________
301,431 - -
___________________________________
Total liabilities 1,221,241 32,347 232,952
===================================
Total equity and liabilities 2,651,246 345,338 317,580
===================================
PROFIT AND LOSS ACCOUNT
HALF YEAR TO 30 NOVEMBER 2007
6 months 6 months Year
ended ended ended
30/11/07 30/11/06 31/5/07
Notes £ £ £
Turnover
Consultancy fees 38,323 77,848 164,957
Sale of goods 930,038 - 92,101
Other income 3,669 - -
___________________________________
Total turnover 972,030 77,848 257,058
Cost of goods sold (489,461) - (58,137)
___________________________________
Gross profit 482,569 77,848 198,921
Overhead costs
Staff costs (178,743) (119,139) (227,793)
Depreciation (6,842) (442) (1,196)
Other operating costs (265,392) (144,828) (384,854)
Exceptional item 3 (149,550) - -
___________________________________
Loss from operations (117,958) (186,561) (414,922)
Net financing cost (25,341) 7,902 11,210
___________________________________
Loss before tax (143,299) (178,659) (403,712)
Income tax expense - - (3,310)
___________________________________
Loss for the period (143,299) (178,659) (407,022)
===================================
Loss per share 2
Basic (0.10 pence) (0.43 pence) (0.97 pence)
Diluted (0.10 pence) (0.43 pence) (0.97 pence)
CASH FLOW STATEMENT
HALF YEAR TO 30 NOVEMBER 2007
6 months 6 months Year
ended ended ended
Notes 30/11/07 30/11/06 31/5/07
£ £ £
Cash flows from operating activities
Cash generated from operating activities 6 (10,767) (209,543) (404,421)
Tax paid - - -
___________________________________
(10,767) (209,543) (404,421)
Cash flows from investing activities
Purchases of property, plant and equipment (111,539) (1,027) (1,963)
Investment in financial asset - (10,000) (11,128)
Acquisition of subsidiary 7 (2,002,547) - -
Interest received 4,314 7,902 11,210
___________________________________
Net cash (used in) investing activities (2,109,772) (3,125) (1,881)
Cash flows from financing activities
Net proceeds on issues of shares 1,488,676 84,793 84,793
Proceeds on issue of loan notes 779,125 - -
Repayment of loan notes (17,381) - -
Interest paid (29,655) - -
___________________________________
Net cash (used in)/from financing activities 2,220,765 84,793 84,793
Net increase/(decrease) in cash
and cash equivalents 100,226 (127,875) (321,509)
Cash and cash equivalents at beginning of year 79,576 401,085 401,085
___________________________________
Cash and cash equivalents at end of year 179,802 273,210 79,576
===================================
Bank balances and cash 179,802 273,210 79,576
===================================
NOTES TO THE ACCOUNTS
1. Accounting policies
The principal accounting policies are as set out in the May 2007 annual report.
The financial statements of The Core Business PLC have been prepared in accordance with International Financial
Reporting Standards (IFRS), IFRIC interpretations endorsed by the European Union and with those parts of the Companies
Act 1985 applicable to companies reporting under IFRS. These financial statements have been prepared under the historic
cost convention.
The preparation of financial statements in conformity with generally accepted accounting principles requires the use of
estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period. Although these estimates are
based on management's best knowledge of the amount, event or actions, actual results ultimately may differ from those
estimates.
2. Loss per share
6 months 6 months Year
ended ended ended
30/11/07 30/11/06 31/5/07
£ £ £
Loss for the purpose of basic loss per share (143,299) (178,659) (407,022)
Loss for the purpose of diluted loss per share (143,299) (178,659) (407,022)
Number of shares 6 months 6 months Year
ended ended ended
30/11/07 30/11/06 31/5/07
No. No. No.
Weighted average number of ordinary shares:
- for the purposes of basic loss per share 138,411,201 41,736,175 42,065,406
- for the purposes of diluted loss per share 138,411,201 41,736,175 42,065,406
The impact of the warrants issued during the year is anti dilutive.
3. Exceptional item
Exceptional items are events or transactions that fall within the activities of the Group and which by virtue of their
size or incidence have been disclosed in order to improve a reader's understanding of the financial statements.
6 months 6 months Year
ended ended ended
30/11/07 30/11/06 31/5/07
£ £ £
Financing costs in respect of acquisition of
Amirose International 149,550 - -
====================================
4. Share capital
6 months 6 months Year
ended ended ended
30/11/07 30/11/06 31/5/07
No. No. No.
Authorised:
Ordinary shares of £0.005 200,000,000 200,000,000 200,000,000
======================================
Issued and fully paid:
Reported as at 1 June 42,396,447 40,276,625 40,276,625
Issue of shares 160,958,730 2,119,822 2,119,822
______________________________________
Reported as at end of period 203,355,177 42,396,447 42,396,447
======================================
6 months 6 months Year
ended ended ended
30/11/07 30/11/06 31/5/07
£ £ £
Authorised:
Ordinary shares of £0.005 each 1,000,000 1,000,000 1,000,000
======================================
Issued and fully paid:
Reported as at 1 June 211,982 201,383 201,383
Issue of shares 804,794 10,599 10,599
______________________________________
Reported as at end of period 1,016,776 211,982 211,982
======================================
On 27 July 2007, the Company raised £1,350,000 through the issue of 135,000,000 new ordinary shares of nominal value 0.5
pence each at a placing price of 1 penny each. This represented 76% of the enlarged issued share capital of the
Company. Warrants were issued to subscribers on a ratio of 1 warrant for every 2 shares subscribed for. The exercise
price of the warrants is 1 penny per ordinary share exercisable at any time up to and including the fifth anniversary of
issue. On the same date the Company issued 4,450,000 new ordinary shares of nominal value 0.5 pence each to
professional advisors and financiers in respect of the acquisition of Amirose International.
On 13 November 2007, the Company raised £200,000 through the issue of 19,047,619 new ordinary shares of nominal value
0.5 pence each at a placing price of 1.05 pence. This represented 9.5% of the enlarged issued share capital of the
Company.
On 28 November 2007, the Company issued 2,461,111 new ordinary shares of nominal value 0.5 pence each in lieu of
professional fees.
At 30 November 2007 warrants over 93,500,000 ordinary shares were outstanding.
Date of At Granted Exercised Forfeits At Exercise/ Exercise/Vesting
grant 1 June /vested 30 Nov Share price date
2007 2007 From To
_________________________________________________________________________________________________________
Warrants
8.03.06 6,500,000 - - - 6,500,000 6.0p 8.03.06 08.03.11
27.07.07 - 87,000,000 - - 87,000,000 1.0p 27.07.07 27.07.12
=========================================================================================================
5. Status of financial information
The interim results for the six months ended 30 November 2007 are unaudited and do not constitute statutory accounts
within the meaning of section 240 Companies Act 1985. The figures for the year ended 31 May 2007 and for the six months
ended 30 November 2006 have been extracted from audited accounts for those periods.
6. Note to the cash flow statement
6 months 6 months Year
ended ended ended
30/11/07 30/11/06 31/5/07
£ £ £
Loss for the period (143,299) (178,659) (407,022)
Adjustments for:
- Taxation - - 3,310
- Finance credits 25,341 (7,902) (11,210)
- Depreciation 6,842 442 1,196
Changes in working capital:
- (Increase)/decrease in trade and
other receivables 209,720 (4,254) (166,620)
- Increase in inventories (164,196) - (5,510)
- Increase/(decrease) in trade and
other payables 54,825 (19,170) 181,435
____________________________________
Cash used in operations (10,767) (209,543) (404,421)
====================================
7. Business combinations
On 27 July 2007 the Company acquired the entire share capital of Amirose International Limited, a beauty products
distributor operating in the UK. The acquired business contributed revenues of £454,082 and net profit of £100,782 to
the group for the period from 27 July to 30 November 2007.
Details of assets acquired and goodwill are as follows:
Cost of acquisition: £
Equity 1,350,000
Loan notes 850,000
Cash 685,930
Directly attributable acquisition costs 282,971
_________________________________________________________________
Total 3,168,901
=================================================================
The equity consideration was satisfied by The Core Business Plc issuing 135,000,000 ordinary shares at a price of 1
penny on 27 July 2007. The issue price consists of the nominal value of the ordinary shares of 0.5 pence and a share
premium of 0.5 pence. Warrants were issued to subscribers on a ratio of 1 warrant for every 2 shares subscribed for. The
exercise price of the warrants is 1 penny per ordinary share exercisable at any time up to and including the fifth
anniversary of issue.
Directly attributable acquisition costs are those charged by the Company's advisers in performing due diligence
activities and producing the acquisition documents.
The total consideration payable for Amirose International Limited is £2,885,930 and comprises £2,600,000 paid on
acquisition subject to a £1 for £1 increase or reduction if the net assets value of Amirose following a verification
exercise at completion was greater or less than £1,234,000.
The net assets acquired at 27 July 2007 were:
Book value at Fair value at
acquisition acquisition
£ £
Non-current assets
Property, plant and equipment 9,162 9,162
Current Assets
Inventories 229,485 229,485
Trade receivables 286,650 286,650
Cash and cash equivalents 1,166,353 1,166,353
________________________________
1,682,488 1,682,488
________________________________
Total assets 1,691,650 1,691,650
================================
Current liabilities
Trade and other payables 70,702 70,702
Current tax payable 101,018 101,018
________________________________
Total liabilities 171,720 171,720
================================
Net assets acquired 1,519,930 1,519,930
================================
Purchase consideration settled in cash 3,168,901
Cash and cash equivalents in subsidiary acquired (1,166,353)
________________________________
Cash outflow on acquisition 2,002,548
================================